Present Study
Material.-32 patients were all suffering from typical gout, with raised serum uric acid levels and normal differential agglutination tests. The average age was 56 years. The average age at onset was 41 years (range 22 to 71), fourteen being aged 25 to 35 years at onset. There were 27 men and five women. Thirteen patients gave a definite family history of gout.
Medication.-Each patient had a period on both Anturan and Urelim. Nine had Anturan and two Urelim continuously for more than a year, and the remaining 21 received the two drugs alternately. In eighteen cases Anturan and Urelim were tried together and separately, and in the same group a third drug, Zoxazolamine (Flexin; 2-amino-5-chlorobenzoxazole), was also tried separately.
The chemical structure of all these drugs is shown in the Figure. In view of our previous finding that 3 -5 g. aspirin given simultaneously with Anturan completely One patient who had taken Zoxazolamine 1*5 g. for one week was given 3 5 g. aspirin in addition for a further week, and the daily urinary uric acid excretion fell from 808 to 580 mg., while the serum uric acid level rose from 1-9 to 3-8 mg./100 ml. (Table, Row 12) .
Paracetamol (N-acetyl-p-amino-phenol; Panadol, Panok).-The four patients on Anturan who had been tested with additional aspirin were also tested with additional paracetamol 3-5 g. daily, and the average daily urinary uric acid excretion fell only very slightly from 770 to 756 mg. (Table, Row 13 ).
The question of analgesics is important in a case presenting both gout and osteo-arthritis, and it appears that paracetamol can be combined with a uricosuric agent without significantly inhibiting the effect of the latter.
Effect of Uricosuric Agents on Blood Coagulation and Serum Cholesterol. Thompson, Mikkelsen, and Willis (1959) , who reviewed the uricosuric effect of various anticoagulants, found that ethylbicoumacetate (Tromexan), bihydroxycoumarin, and anisindione produced uricosuria. Kohn and Prozan (1959) , who found that a series of patients with acute myocardial infarction had serum uric acid levels above 6 mg./100 ml., suggested that the exhibition of uricosuric drugs might afford some protection against coronary atherosclerosis.
Gertler and White (1954) 
Subject Improvement and Side-Effects
All patients claimed that they had improved rather than deteriorated during the 2 years, in that they were now having fewer attacks of gout and often had less general stiffness.
Eleven patients preferred Anturan. The reason was that they felt less "tired" and had less general stiffness and interval pain, probably because of the slight anti-inflammatory effect of this preparation.
Two patients preferred Urelim. One had developed boils while taking Anturan, but the white cell count remained normal and the boils did not recur on re-administration of Anturan. The other thought he had fewer attacks of gout while taking Urelim.
Of 21 patients who were transferred from Anturan to Zoxazolamine, five stated that they felt a "little tired" while taking the Zoxazolamine, one felt "muzzy" during the first 3 days of treatment, and one had slight headaches. Eight were equally well with either drug, but ten preferred Anturan and three Zoxazolamine.
Two patients had slight dyspepsia, but not sufficient to make one consider stopping medication during a minimum period of 6 weeks.
Course of the Disease
During the first 6 weeks of treatment there was a tendency to increase in the frequency of attacks of gout, but after this period there was marked lessening of frequency and severity. During this first 6 weeks, colchicine 0-5 mg. was given three times a day, and, if in spite of this, attacks occurred, phenylbutazone 600 mg. daily for 2 days was always completely successful in checking them.
In six instances there was a definite softening or decrease in the size of the tophi, and two patients reported some change in this direction after only 6 weeks' therapy. Summary 32 patients with typical gout have been observed during treatment with uricosuric agents for at least 2 years, in continuation of the studies reported by Kersley and others (1958) .
Anturan and Urelim were found to have a satisfactory effect both alone and in combination, and a similar effect was produced by the administration of Zoxazolamine.
Aspirin inhibited the uricosuric effect of all these drugs, but paracetamol did not do so.
Estimations were also made of the serum cholesterol and prothrombin times, with the idea of testing the theory that serum cholesterol and uric acid levels are related.
All the patients treated felt subjective benefit, although some felt better on one drug, and some on another. Toxic effects were rare and extremely slight, but on the whole Anturan was the favourite drug and the least toxic.
Because the numbers of patients who could be tested with each drug varied, and only a few could be observed daily for months in hospital, these results cannot collectively be subjected to statistical analysis. They show clearly, however, the great value, potency, and safety of the newer uricosuric drugs in the treatment of gout, with perhaps Anturan leading the field. Further work is required on the combined use of these drugs-e.g. the potentiation of Anturan by Urelim-and in particular on the degree of inhibition exerted by various dosages of other drugs, especially of the aspirin type. The possible importance of dosage inhibition is emphasized by the recent paper of Yu and Gutman (1959) .
Agents uricosuriques dans la goutte R1tsuMt A la suite des travaux rapport6s par Kersley, Cook, et Tovey (1958) , on a observe 32 malades atteints de goutte classique et traits par des agents uricosuriques pendant au moins deux ans.
Anturan et Urelim ont donned des resultats satisfaisants, aussi bien seuls qu'en combinaison, et on a obtenu un effet similaire avec Zoxazolamine.
L'aspirine inhibait l'effet uricosurique de tous ces produits, mais le paracetamol ne l'inhibait pas.
On a procede aussi a des determinations du cholesterol serique et du temps de prothrombine, pour verifier la theorie qu'il y avait un rapport entre les taux de cholesterol serique et d'acide urique.
Tous les malades traits ont accuse une amelioration subjective, bien que certains d'entre eux en preferaient un produit a un autre. de Yu y Gutman (1959) .
